BiotechTube
Home/Hansa Biopharma/Maria Törnsén
MT

Maria Törnsén

Chief Operating Officer and President U.S.

Hansa Biopharma

Therapeutic Areas

Autoimmune DiseasesTransplantationGene Therapy

Hansa Biopharma Pipeline

DrugIndicationPhase
ImlifidaseDesensitization in Kidney TransplantationApproved (EU)
HNSA-5487Next-Generation IgG-cleaving EnzymePreclinical/Clinical

Leadership Team at Hansa Biopharma

RA
Renée Aguiar-Lucander
Chief Executive Officer
HK
Hitto Kaufmann
Chief Scientific & Technology Officer
EB
Evan Ballantyne
Chief Financial Officer
View full Hansa Biopharma profile